TELA Bio (TELA) Shares Outstanding (2018 - 2026)

TELA Bio has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $57.4 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 45.04% year-over-year to $57.4 million in Q2 2026; TTM through Jun 2026 was $57.4 million, a 45.04% increase from a year earlier, with the FY2025 full-year figure at $44.5 million, up 56.13% from the prior year.
• Shares Outstanding (Entity) was $57.4 million for Q2 2026 at TELA Bio, roughly flat from $57.3 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $57.4 million in Q2 2026, with the low at $14.6 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $30.1 million, with a median of $24.7 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) grew 0.59% in 2022, then surged 68.13% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $19.2 million in 2022, then climbed by 27.81% to $24.5 million in 2023, then grew by 16.46% to $28.5 million in 2024, then soared by 56.13% to $44.5 million in 2025, then grew by 28.91% to $57.4 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $57.4 million (Q2 2026), $57.3 million (Q1 2026), and $44.5 million (Q4 2025), per Business Quant data.